Sign in

You're signed outSign in or to get full access.

Quentin Helmer

Research Analyst at Stifel Financial Corp.

Quentin Helmer is an Analyst at Stifel, Nicolaus & Company, Incorporated, specializing in equity research within the institutional group, though specific sector or company coverage information is not publicly listed. While detailed performance metrics and third-party rankings are not available in public sources, Helmer’s role at a leading investment bank suggests experience producing actionable research for Canadian and cross-border markets. He began his current position at Stifel after advancing through earlier career stages in financial research or analysis, as is typical within the firm, but direct prior employment details remain undisclosed. Official public records do not provide information on Helmer’s securities licenses or regulatory credentials, though analysts in similar Stifel roles generally maintain all required FINRA or Canadian Investment Regulatory Organization registrations.

Quentin Helmer's questions to Everus Construction Group (ECG) leadership

Question · Q1 2025

Quentin Helmer, on behalf of Brian Brophy at Stifel, questioned Everus's capabilities and strategy in the pharmaceutical manufacturing market and asked for an update on work related to wildfire mitigation in California, including any near-term spending impacts.

Answer

Executive Jeff Thiede identified biopharmaceuticals as a key focus for growth, to be pursued through both organic expansion and M&A. Regarding wildfire mitigation, Thiede confirmed Everus is well-positioned for undergrounding work in California, citing a long history of success, renewed Master Service Agreements (MSAs) with a long-standing customer, and a strong safety record, positioning them to continue pursuing this type of work.

Ask follow-up questions

Fintool

Fintool can predict Everus Construction Group logo ECG's earnings beat/miss a week before the call

Question · Q1 2025

Quentin Helmer, on behalf of Brian Brophy at Stifel, asked about Everus's capabilities and strategic opportunities in the pharmaceutical manufacturing market. He also inquired about the company's work in California related to wildfire mitigation and whether there has been any near-term impact on utility spending in that area.

Answer

Executive Jeff Thiede identified pharmaceutical and biopharmaceutical manufacturing as a key focus market for growth, to be pursued through both organic expansion and potential M&A. Regarding wildfire mitigation, Thiede confirmed Everus is well-positioned with a long history of success in undergrounding work in Southern California, noting the company has renewed Master Service Agreements (MSAs) with a long-standing customer in the region.

Ask follow-up questions

Fintool

Fintool can write a report on Everus Construction Group logo ECG's next earnings in your company's style and formatting